VC fund profile · evidence-aware directory data
Threshold Ventures stages, portfolio and investment profile
Threshold Ventures partners with founders building technology businesses and lists Probably Genetic in its official portfolio. Fierce Healthcare named Threshold as the lead investor in Probably Genetic's $12M Series A reported October 14, 2026, including comments from managing partner Emily Melton. Individual investor allocations and round valuation were not disclosed.
Keep track of Threshold Ventures
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Series A
Participates: Series A
Sector focus
Not recorded
Geography
Not recorded
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
1
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-20. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list Threshold Ventures as an investor (1 total).
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.